Skip to main content

Peer Review reports

From: Antitumor effects of erlotinib in combination with berberine in A431 cells

Original Submission
17 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Aug 2022 Reviewed Reviewer Report
8 Jan 2023 Reviewed Reviewer Report - Johanna Varghese
23 Jan 2023 Author responded Author comments - Yanping Huang
Resubmission - Version 3
23 Jan 2023 Submitted Manuscript version 3
24 Jan 2023 Author responded Author comments - Yanping Huang
Resubmission - Version 4
24 Jan 2023 Submitted Manuscript version 4
10 Feb 2023 Reviewed Reviewer Report - Johanna Varghese
1 Mar 2023 Author responded Author comments - Yanping Huang
Resubmission - Version 5
1 Mar 2023 Submitted Manuscript version 5
1 Mar 2023 Author responded Author comments - Yanping Huang
Resubmission - Version 6
1 Mar 2023 Submitted Manuscript version 6
Publishing
7 Mar 2023 Editorially accepted
11 May 2023 Article published 10.1186/s40360-023-00661-2

You can find further information about peer review here.

Back to article page